🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Energy Sector SEC Filings — August 12, 2026

The three filings from the S&P 500 Energy sector on August 12, 2026, reveal a sector marked by divergent insider sentiment and passive institutional positioning. APA Corp's 13G/A filing shows a major passive holder, Hotchkis & Wiley, maintaining a significant 8.97% stake, indicating steady institutional confidence without active control intent. In contrast, Phillips 66's Form 4 filings signal a strong bearish insider signal: Executive VP Mandell Brian executed a net sale of $4.9M in stock, including a large $6.45M sale, which may reflect personal portfolio diversification or a lack of conviction in near-term valuation. Texas Pacific Land Corp saw a minimal insider purchase of 1 share by a 10% owner, a token gesture that does not offset the broader negative signal from Phillips 66. Period-over-period data was not available in these filings, limiting trend analysis, but the insider activity pattern suggests a cautious outlook among senior executives at a major refiner, while passive funds remain committed to upstream E&P names like APA.

2 high priority 1 medium 3 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — August 12, 2026

The Consumer Staples sector is showing a clear pattern of insider profit-taking and capital recycling, with three major filings (McCormick, Church & Dwight, Hershey) revealing significant insider sales totaling over $12.3 million. The most notable is McCormick's former Executive Chairman Lawrence Kurzius, who exercised and immediately sold 205,538 shares ($10.8M), reducing his stake to 1.6% of the company, a signal of reduced conviction at the top. Hershey's 10% owner (Milton Hershey School Trust) also systematically sold shares under a 10b5-1 plan, indicating a planned liquidity event. In contrast, Estée Lauder's passive 7.5% stake filing by Managed Account Advisors suggests institutional confidence in the beauty giant's long-term value. ADM's board resignation is a non-event, but the timing (year-end 2026) adds a minor governance transition risk. Overall, the sector is experiencing insider de-risking, with no major bullish capital allocation signals (buybacks, dividends) reported, pointing to a cautious near-term outlook.

6 high priority 1 medium 7 total filings
· daily

S&P 500 Industrials Sector SEC Filings — August 12, 2026

The latest batch of 10 filings from the S&P 500 Industrials stream reveals a pronounced divergence in management and major shareholder sentiment across the sector. While the overall filing activity is dominated by insider transactions (Form 4 filings) and passive institutional ownership disclosures (Schedule 13G), the data points to a clear pattern of **c-suite profit-taking** at General Dynamics, GE, and Emerson Electric, contrasting sharply with a massive **$45.8M insider buy** at Republic Services. The period-over-period data is sparse in these specific filings, but the insider activity provides a powerful, real-time signal on management conviction. The most actionable intelligence comes from the insider trading patterns, which suggest a bearish tilt among executives at legacy industrial conglomerates, while a major 10% owner is aggressively accumulating shares in the waste management sector. The institutional filings (13G/A) show passive, large-scale ownership in Carrier Global and Northrop Grumman, indicating stable, long-term institutional interest. The UPS debt issuance filing is a routine capital markets transaction with no performance implications. The Lockheed Martin 13F-HR provides a window into corporate treasury allocation, showing a heavy tilt towards mega-cap tech and broad market ETFs, a neutral but informative data point on internal capital allocation views.

5 high priority 5 medium 10 total filings
· daily

US Material Events SEC 8-K Filings — August 12, 2026

The August 12, 2026 filings reveal a market actively managing balance sheets through refinancing, capital raises, and strategic M&A, while corporate governance changes and restatements signal underlying stress. Key themes include liability management (Charter, American Airlines, Southwest), equity issuance for growth and liquidity (Ryman, Sky Harbour, ACRES), and transformative M&A (AEVEX, Modiv/GNL). Financial performance is mixed: OptimizeRx and Stem show revenue declines but margin improvements, while Crown Crafts and PubMatic show positive trends. Insider activity is limited, but notable director departures at SPAR Group and a CFO change at BitGo warrant attention. Forward-looking guidance is largely reaffirmed, with key catalysts including ArriVent's Phase 3 data and AEVEX's acquisition close. Overall, the digest points to a cautious but active corporate environment, with selective opportunities in companies demonstrating operational resilience and strategic clarity.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — August 12, 2026

The August 12, 2026 batch of Dow 30 filings reveals a bifurcated picture: robust AI-driven growth at Cisco contrasts with leadership uncertainty at Home Depot and insider selling at Merck. Cisco's record Q4 revenue ($17.3B, +18% YoY) and raised AI guidance ($4B in Q4 orders) underscore a powerful secular tailwind, while its management's routine tax-withholding insider transactions are neutral. However, a material risk flag emerges from Merck, where the Animal Health President sold ~$4.4M in stock, signaling potential concern. Home Depot's CEO medical leave introduces short-term operational risk, though the company's succession plan is orderly. JPMorgan's 13F reveals a $7.26B long position in AbbVie, a bullish signal for the pharma sector. Across the board, insider activity is largely neutral (tax withholdings), but the lack of open-market buying is notable. The key themes are AI infrastructure acceleration, pharma insider divergence, and consumer/industrial leadership stability.

13 high priority 3 medium 16 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — August 12, 2026

Both filings on August 12, 2026, reveal acute distress in micro-cap companies listed on Nasdaq, with CID Holdco (Dot Ai) and Generation Income Properties facing imminent delisting due to market value and bid price deficiencies. The common theme is a failure to maintain minimum listing standards despite prior compliance efforts, signaling severe liquidity and market confidence issues. CID Holdco's stock has collapsed in value, failing to meet the $50M MVLS threshold, while Generation Income Properties cannot sustain a $1.00 bid price and now faces a compounding equity deficiency. Neither company has shown any period-over-period revenue growth or margin improvement in the enriched data, and both lack insider buying or positive forward guidance, reinforcing a bearish outlook. The market implications are binary: delisting would likely trigger further price declines and loss of institutional access. These cases highlight a broader trend of struggling micro-caps unable to reverse valuation erosion in a selective market environment.

2 high priority 2 total filings
· daily

Global High-Priority Regulatory Events — August 12, 2026

The August 12, 2026 digest is dominated by a wave of corporate distress and restructuring, with 12 filings related to insolvency, bankruptcy, or delisting, and 20 filings involving mergers, acquisitions, or business combinations. The most critical development is the convergence of multiple high-risk events: Simbhaoli Sugars' deepening insolvency with an adverse audit opinion, the forced delisting of CID Holdco (Dot Ai) and Agriculture & Natural Solutions Acquisition Corp, and the Nasdaq non-compliance of Generation Income Properties. On the M&A front, the completion of Modiv Industrial's merger with Global Net Lease and the SEC effectiveness of the Inflection Point Acquisition Corp. V / GOWell business combination signal active SPAC consolidation. A notable trend is the aggressive expansion of Indian companies into new subsidiaries and joint ventures, with 10 filings detailing new incorporations or stake acquisitions, often in early-stage entities with nil turnover. Period-over-period data reveals a stark contrast: Lenskart Solutions posted strong 30.6% YoY revenue growth, while Sudarshan Chemical Industries saw a 27.5% YoY revenue decline, and Stem Inc. reported a 12% YoY revenue drop. The overall sentiment is heavily negative, with a high concentration of risk flags in the Indian corporate insolvency space and US-listed companies facing delisting, but select opportunities exist in the turnaround of Nova Iron & Steel and the high-growth acquisition by UVS Hospitality.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 12, 2026

The August 12, 2026, filing set reveals a market bifurcated between high-growth, cash-burning companies and stable, income-oriented institutions. A dominant theme is the aggressive capital expenditure and debt-fueled expansion in the tech and infrastructure sectors, exemplified by WhiteFiber's 54.5% revenue surge but 51% cash decline, and Applied Aerospace's 47.4% revenue growth offset by a $154M net loss from IPO costs. Conversely, the healthcare sector shows a stark contrast between commercial-stage success (Protalix's $22.1M net income swing) and pre-revenue cash burn (Onconetix's going-concern risk). The financial filings are dominated by passive 13F snapshots, revealing a broad institutional preference for mega-cap tech and fixed-income ETFs, with notable exceptions like Condor Capital's $1.33B ETF-heavy portfolio and Marathon Trading's aggressive use of options for hedging and speculation. Key period-over-period trends include margin compression in mature industrials (Utah Medical Products, Air Industries Group) and a shift toward shareholder returns, with Arbutus planning a $230M buyback from a litigation settlement. The most critical developments are the $510M dilutive acquisition by Ming Shing Group, the $225M capital raise by Altimmune for a Phase 3 trial, and the securities class action lawsuit against Datavault AI, all of which carry significant market implications for their respective sectors.

10 high priority 40 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 12, 2026

The latest batch of 9 filings for the S&P 500 Consumer Discretionary stream reveals a sector dominated by passive institutional positioning, with Capital Group entities (Capital World Investors, Capital Research Global Investors) making notable disclosures in Chipotle, Starbucks, Nike, and Carvana. The most actionable signal comes from Aptiv PLC, where a director made a significant open-market purchase of $552K at ~$50.21-$50.29, a strong vote of confidence given the stock's recent pullback. Home Depot's 8-K introduces a temporary leadership vacuum as CEO Ted Decker takes medical leave, creating near-term uncertainty for the 2,361-store giant. Period-over-period comparisons are limited in these filings, but the insider buying at Aptiv and the stable, passive stakes across the consumer giants suggest a sector that is attractively valued but lacking immediate catalysts. The absence of forward-looking guidance or capital allocation changes in most filings points to a wait-and-see posture from management teams. The key portfolio-level pattern is the concentration of large passive holders (Capital Group) across multiple consumer discretionary names, indicating a coordinated or thematic allocation to the sector.

2 high priority 7 medium 9 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 12, 2026

Today's healthcare filings are dominated by insider trading activity, revealing a clear divergence in management sentiment. Pfizer CEO Albert Bourla made a notable $1M open-market purchase, signaling strong conviction at a depressed valuation, while multiple executives at Regeneron, Merck, and Becton Dickinson executed significant sales, often via 10b5-1 plans. The sector also saw a passive institutional stake disclosure in Moderna by Capital World Investors, indicating steady interest despite the company's challenges. The overall pattern suggests a bifurcated market: large-cap pharma with strong pipelines and cash flows are attracting insider buying, while high-growth or device companies are seeing profit-taking. No period-over-period financial trends or forward-looking guidance were available in these filings, limiting the ability to assess operational momentum. The most actionable signal is the bullish insider activity at Pfizer, which contrasts with the broader selling trend.

8 high priority 1 medium 9 total filings
· daily

US Earnings Financial Results SEC Filings — August 12, 2026

The 50 filings for the period ending mid-2026 reveal a market characterized by a stark divergence between top-line growth and bottom-line profitability. While several companies, particularly in infrastructure (Cardinal, CoreWeave) and consumer (CAVA, Nucor), posted robust revenue growth, a significant number of firms are experiencing margin compression and widening net losses due to rising costs, heavy investment, and non-cash charges. A notable theme is the prevalence of 'mixed' sentiment, with 27 out of 50 filings showing both positive and negative signals, often driven by strong revenue growth offset by surging operating expenses and interest costs. Insider trading activity was notably absent from the enriched data, limiting one key signal source. Capital allocation trends show a bifurcation: mature companies like Nucor are returning capital via buybacks and dividends, while growth and pre-revenue firms are aggressively raising capital through equity and debt offerings to fund operations and expansion. The healthcare and biotech sector is a major focal point, with several companies (Liquidia, Protalix) achieving dramatic turnarounds, while others (Sutro, Arbutus) face significant revenue volatility. The data suggests investors should prioritize companies demonstrating operating leverage and cash flow discipline over those solely focused on top-line expansion.

50 high priority 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 12, 2026

This digest of four pre-analyzed proxy filings reveals a stark divergence in corporate governance and financial health across the US equity market. The most critical development is at **Beauty Health Co (SKIN)**, where a severe liquidity crisis is unfolding: the company faces a potential $353.2M note repurchase obligation if a reverse stock split fails, far exceeding its $206.1M cash position, creating a high-probability distress scenario. In contrast, **Fossil Group, Inc.** is pursuing a more standard governance refresh, reducing its board size and seeking shareholder approval for a compensation plan amendment, indicating a focus on long-term incentive alignment. **Thirdline Real Estate Income Fund** is navigating a structural transition via a planned acquisition, with a special meeting to approve new trustees and an advisory agreement that maintains fee levels, suggesting a neutral, orderly transition. **FutureFuel Corp.** presents the most routine filing, with a standard director election and auditor ratification, lacking any financial performance data or material period-over-period trends. The overarching theme is one of risk asymmetry: one company is in a fight for survival, while others are engaged in normal governance housekeeping. No insider trading activity was reported in any of the filings, and no forward-looking guidance or capital allocation changes were disclosed, limiting the depth of trend analysis but sharpening the focus on the acute risk at Beauty Health.

4 high priority 4 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 12, 2026

The IPO pipeline for August 12, 2026, shows a mixed landscape dominated by pre-revenue biotech, cash-constrained fintech, and SPAC mergers with space-tech and data-analytics targets. Six filings were analyzed: two S-1s (Onconetix, BirchBioMed) and two S-1s with financial data (Fast Finance Pay Corp, SharonAI), plus two S-4 SPAC combinations (Space-Eyes, Mobilewalla). Period-over-period data reveals diverging financial health: Onconetix shows zero revenue momentum and a $135.4M accumulated deficit, while Fast Finance Pay Corp turned a $3.2M loss into $186K net income YoY but still burns cash. Space-Eyes and Mobilewalla represent high-risk/high-reward SPAC targets with $172.5M and $174.9M trust proceeds respectively, but face redemption risk. BirchBioMed's blank S-1 (no financials, no business description) signals a hollow or early-stage filing. The overarching theme is capital starvation in early-stage healthcare and fintech, contrasted by well-funded SPAC vehicles chasing space and data monetization.

6 high priority 6 total filings
· daily

US SEC Trading Suspension Halt Orders — August 12, 2026

Two Nasdaq-listed companies, CID Holdco, Inc. (Dot Ai) and Generation Income Properties, Inc., received Staff Determinations on August 6, 2026, to delist their securities due to non-compliance with listing standards, highlighting a severe liquidity and market confidence crisis in the micro-cap space. Both companies face imminent deadlines to appeal by August 13, 2026, but their financial fundamentals are deeply compromised, with no period-over-period revenue growth or positive operational metrics reported. CID Holdco failed to maintain a $50 million Market Value of Listed Securities (MVLS) despite regaining compliance on bid price, while Generation Income Properties failed the minimum bid price rule and a new deficiency in market value of publicly held shares. The absence of insider buying, positive forward guidance, or capital allocation actions (dividends/buybacks) in either filing underscores a complete lack of management conviction and financial flexibility. These delisting events signal a broader pattern of distress among micro-cap issuers with low market capitalizations and no path to organic compliance, creating high-risk situations for existing shareholders and potential forced selling. The compressed timeline for hearings and the lack of any positive catalysts make these filings actionable only for short sellers or those monitoring for complete equity wipeouts. No period-over-period comparisons, insider transactions, or forward-looking statements were available in the enriched data, limiting trend analysis but reinforcing the binary nature of the outcomes.

2 high priority 2 total filings
· daily

US Executive Officer Management Changes SEC — August 12, 2026

Today's digest covers 30 filings, with the first 23 newly published. The most material event is **BitGo Holdings**' CFO transition and simultaneous disclosure of a net loss, signaling governance stability but financial strain. **OptimizeRx** shows a concerning 30% YoY revenue decline, yet management reaffirms guidance, a mixed signal. **Arrive AI** faces a severe liquidity crunch triggered by a stock price floor provision, while **SPAR Group** reveals a bitter boardroom conflict with two directors removed for breach of agreement. **Home Depot**'s CEO medical leave is a high-profile but orderly succession event. Across the set, insider activity is minimal, but forward-looking data from OptimizeRx and Crown Crafts provides key calendar items. A pattern of weak shareholder support is evident at **PetMed Express**, where director elections saw significant opposition. The overall sentiment is neutral to negative, with governance and liquidity risks dominating.

30 high priority 30 total filings
· daily

US Corporate Board Director Changes SEC Filings — August 12, 2026

The 30 filings reveal a boardroom landscape dominated by routine governance transitions, with a few high-impact events creating actionable signals. The most critical development is the forced resignation of two directors at SPAR Group following a breach of agreements, signaling severe governance dysfunction. Conversely, strategic appointments at PubMatic, Madrigal Pharmaceuticals, and Citius Oncology suggest focused efforts to bolster commercial execution and R&D expertise. Financially, the data is mixed: OptimizeRx reported a 30% revenue decline but beat consensus, while Crown Crafts swung to profitability on tariff refunds. Insider activity is limited, but the CFO transition at BitGo and the CEO medical leave at Home Depot create near-term uncertainty. Key themes include a focus on independent board refreshment, a trend toward internal promotions for CFO roles, and notable shareholder dissent at PetMed Express. The overall risk profile is moderate, with opportunities in companies executing strategic hires against a backdrop of improving fundamentals.

30 high priority 30 total filings
· daily

US Merger & Acquisition SEC Filings — August 12, 2026

The August 12, 2026, M&A digest is dominated by a surge in SPAC activity, with five blank-check companies (BOA Acquisition Corp. II, OceanLight Acquisition Corp, TCGX Acquisition Corp, Inflection Point Acquisition Corp. V, and Embrace Change Acquisition Corp.) advancing their lifecycles through IPOs, regulatory approvals, or charter amendments to facilitate business combinations. The most material event is the completion of Modiv Industrial's merger into Global Net Lease, Inc., a high-certainty closure that removes a public entity. A notable operational outlier is Stem, Inc., which reported a mixed quarter with a 12% YoY revenue decline but a 63% surge in adjusted EBITDA and a 600 bps improvement in non-GAAP gross margins, alongside a strategic asset acquisition. The digest also includes two opaque filings (XMax Inc. and Pelican Acquisition II Corp) with no deal specifics, representing information gaps. The overarching theme is a busy SPAC pipeline with several companies nearing de-SPAC milestones, creating a binary event-driven catalyst calendar for the coming weeks.

12 high priority 12 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 12, 2026

Overnight filings reveal a market bifurcated between aggressive growth investment and insider profit-taking. Key themes include a surge in director-level stock awards at Nu Holdings and STEM, signaling long-term alignment, contrasted with substantial insider selling at LandBridge Co LLC ($93.8M) and Charles Schwab ($5.01M). Earnings reports from Amcor and BETA Technologies show strong top-line growth driven by M&A and defense contracts, but with widening losses and cautious forward guidance, creating a mixed sentiment. Institutional filings from AI-Squared and Westpac highlight a continued focus on mega-cap tech and Chinese ADRs. The most actionable signals center on the transformative Berry acquisition at Amcor, the strategic investment in GCL Global's gaming subsidiary, and the complete exit of Goldman Sachs from Cantaloupe, which may indicate a loss of confidence in the stock.

34 high priority 16 medium 50 total filings